You are here: Introduction > Marketing authorisation numbers
 
        PreviousNo next
 
Program Plus Tablets:  Marketing authorisation numbers
 
 
Program Plus Tablets
Marketing authorisation numbers
Milbemycin oxime/lufenuron 2.3 mg/46 mg
Vm 18352/4000
Milbemycin oxime/lufenuron 5.75 mg/115 mg
Vm 18352/4001
Milbemycin oxime/lufenuron 11.5 mg/230 mg
Vm 18352/4002
Milbemycin oxime/lufenuron 23 mg/460 mg
Vm 18352/4003
           
 
        PreviousNo next
  Date updated: 25 September 2006